In addition to the phenotypic variability associated with the classical dominantly acting cancer susceptibility genes there is evidence of increased cancer risk in carriers of recessive cancer syndrome mutations; exemplified by heterozygous ATM mutations associated with a two-fold elevated breast cancer risk [31]. Here, ATM is linked to breast cancer.